January 07, 21 - 9:18 am - LABS

Brazil pharmaceutical firm to request emergency use for Russia’s Sputnik V vaccine in February

Brazilian pharmaceutical company União Química aims to request authorization for emergency use of Russia’s Sputnik V coronavirus vaccine in the second half of February, its head told Valor Econômico on Thursday.

According to the newspaper, the first doses of the Russian vaccine might be available for Brazilians next month, once the company secured approval from health regulator Anvisa.

Production of the Sputnik V vaccine is scheduled to start in January in Brazil, according to União Química’s CEO. Once at full capacity, União will be able to make 8 million doses per month at a facility in central Brazil, he said.